BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26103989)

  • 1. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
    Ung TH; Malone H; Canoll P; Bruce JN
    CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-enhanced drug delivery for glioblastoma: a review.
    D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
    J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
    Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
    Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced delivery for the treatment of glioblastoma.
    Vogelbaum MA; Aghi MK
    Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.
    Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK
    J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of convection enhanced delivery of toxins in humans.
    Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
    Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convection-enhanced delivery in the treatment of malignant glioma.
    Lopez KA; Waziri AE; Canoll PD; Bruce JN
    Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
    Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
    J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
    Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
    Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
    Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS
    Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept.
    Halle B; Marcusson EG; Aaberg-Jessen C; Jensen SS; Meyer M; Schulz MK; Andersen C; Kristensen BW
    J Neurooncol; 2016 Jan; 126(1):47-55. PubMed ID: 26428358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
    Shi M; Fortin D; Paquette B; Sanche L
    Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of convection-enhanced delivery in the treatment of brain tumors.
    Bidros DS; Liu JK; Vogelbaum MA
    Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.